Home monitoring of wet AMD offers high-quality scans: Patients can get real-time disease monitoring with self-operated device.

Lynda Charters, Anat Loewenstein

Research output: Contribution to specialist publicationArticle

Abstract

The article discusses the feasibility of a longitudinal at-home pilot study on wet age-related macular degeneration (AMD) via a patient self-operated device, automated data transmission, and disease surveillance analysis in 2021. It states that daily monitoring can reduce office visits, detect reoccurrence early, and eliminate unnecessary routine injections of antivascular endothelial growth factor (VEGF) therapy. Also noted is the resulting automated analysis' sagreement with human grading.
Original languageEnglish
Pages18-19
Number of pages2
Volume46
No16
Specialist publicationOphthalmology Times
PublisherMJH Life Sciences
StatePublished - 1 Oct 2021

Fingerprint

Dive into the research topics of 'Home monitoring of wet AMD offers high-quality scans: Patients can get real-time disease monitoring with self-operated device.'. Together they form a unique fingerprint.

Cite this